Our recent advisory board meetings brought together leading experts from across primary and secondary care, clinical specialisms and job roles to shape a content programme that is both clinically relevant and strategically aligned with current NHS priorities. The insights ensure the programme reflects the realities delegates face in practice, while equipping them with the tools to drive meaningful change.

Insights from our advisory board and programme development discussions have been instrumental in shaping a content programme that is both clinically rigorous and highly practical. A clear message emerged: education must reflect real-world multiple long-term condition management. Patients do not present in silos, and neither should learning.

As such, the programme has been designed to bring together perspectives across specialties, focusing on how different conditions interact and how care can be delivered more holistically. Bringing together cardiovascular, renal and metabolic health reflects the reality that these conditions are deeply interconnected, driven by shared risk factors.

A central theme emerging from the discussions was the importance of a programme founded in practical, implementable learning. Delegates are looking for more than theory, they want clear, actionable strategies that can be applied across care settings. As a result, a key priority is simplifying CVRM into “bread and butter” clinical practice. Therefore, the programme will prioritise case-based learning, real-world examples and guidance that supports confident decision-making for people living with multiple long-term conditions.

The advisory board played a key role in shaping the theatre structure and naming, ensuring it is aligned to delegate needs. Rather than specialty silos, theatres will be organised around broader themes to signpost the aims of the programme. This approach supports a more holistic understanding of condition management.

The Keynote Theatre will anchor the programme, bringing together key policy updates and big-picture thinking to set the direction of CVRM care. Two dedicated clinical theatres will deliver deep dives into core disease areas, guideline updates and therapeutic advances across cardiovascular, renal and metabolic care. Recognising the strong demand for practical, skills-based learning, Clinical Theatre 2 will transition into Practical Workshops on day two, creating space for more interactive sessions focused on applying knowledge to real-world scenarios. Alongside this, the Integrated Care & Pathways Theatre will focus on how services are designed and delivered across systems. It will explore multidisciplinary collaboration, pathway redesign and strategies to reduce variation and improve patient outcomes.

The configuration of theatres reflects a deliberate shift away from siloed learning, encouraging delegates to move between strategic, clinical and practical content while reinforcing the interconnected nature of CVRM care.

The advisory board conversations highlighted the growing need for more integrated approaches to CVRM care. With patients increasingly presenting with overlapping cardiovascular, renal and metabolic conditions, siloed care models are no longer sufficient. The content programme will therefore place strong emphasis on cross-specialty collaboration. The event will explore how multidisciplinary teams can work more effectively to improve outcomes, reduce fragmentation and address health inequalities.

Prevention and early intervention were also key priorities. From lipid management and diabetes optimisation to slowing CKD progression and reducing cardiovascular risk, the programme will explore how clinicians can shift from reactive to proactive care models. This aligns closely with broader NHS ambitions and reinforces the role of healthcare professionals as drivers of population health improvement.

With new treatments, evolving guidelines and increasing use of digital tools, there is a clear demand for education that builds confidence and supports clinicians navigating rapid therapeutic and technological advancements. Sessions will therefore focus on emerging therapies, guideline updates and the practical integration of digital health and data into routine care.

The programme will also address some of the most pressing challenges identified through research and advisory discussions. These include tackling clinical inertia, building confidence in the use of newer therapies such as SGLT2 inhibitors and GLP-1 receptor agonists, and addressing gaps in knowledge around areas such as fatty liver disease. There will also be a strong focus on obesity as a key driver of CVRM conditions, alongside prevention strategies that can reduce long-term risk and improve outcomes.

Ultimately, what sets the content programme at CVRMPC apart is its unification of specialisms in one place. In a landscape defined by rising demand, workforce pressures and increasing clinical complexity, the need for integrated, practical and forward-thinking education has never been greater. It is a must-attend for professionals working across the CVRM pathway.